iifl-logo

Gland Pharma Ltd Historical Data

Add as a Preferred Source on Google
₹3,061.8
(-0.56%)
Oct 9, 2026|03:55:39 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Gland Pharma Ltd Historical Data

11/09/2026calendar-icon
11/10/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

09-Sep-2026

2,959.3

3,033.92,938.63,026.21,00,4454,68,04,13,085.48,89,055

10-Sep-2026

3,031

3,0312,918.92,946.930,0871,09,47,10,675.71,78,191

11-Sep-2026

2,940

2,950.12,8822,922.343,6631,13,47,46,423.41,84,335

15-Sep-2026

2,930

2,9402,856.92,895.547,2491,44,17,92,553.63,05,756

16-Sep-2026

2,877

2,914.22,792.42,826.658,8162,12,43,41,402.64,64,467

17-Sep-2026

2,827.9

2,941.12,820.12,907.850,8441,97,22,92,729.74,20,164

18-Sep-2026

2,907.2

2,9782,9042,961.944,3191,45,62,89,749.33,19,412

21-Sep-2026

2,965

3,0082,916.22,940.232,17482,77,01,073.51,40,920

22-Sep-2026

2,944.9

2,968.42,9002,916.620,90836,34,35,412.164,821

23-Sep-2026

2,913

2,938.82,888.12,910.225,28246,68,10,79173,868

24-Sep-2026

2,896

2,933.22,875.12,897.428,36395,33,70,8402,21,319

25-Sep-2026

2,885

2,9272,8822,917.216,87536,19,04,44062,645

28-Sep-2026

2,910

2,9282,884.22,89621,88364,84,96,811.21,56,998

29-Sep-2026

2,896.6

3,0242,896.62,989.765,7642,62,02,00,652.84,05,761

30-Sep-2026

2,990

3,007.72,8722,899.448,4571,55,52,15,750.72,40,163

01-Oct-2026

2,876

2,929.82,841.12,874.433,20594,20,67,783.11,87,759

05-Oct-2026

2,890

2,9202,863.12,911.538,82772,11,67,255.31,78,122

06-Oct-2026

2,921.1

3,019.82,898.13,006.154,7771,11,62,54,343.32,41,406

07-Oct-2026

3,026

3,1713,0193,150.689,0704,17,57,31,967.55,63,797

08-Oct-2026

3,162

3,170.53,049.53,079.147,5281,53,55,06,791.82,31,886

Gland Pharma: Related NEWS

Gland Pharma Stock Gains 7% as Q3 Revenue Climbs 22.5% to ₹1,695.3 Crore

The European business reported a 54 percent year on year surge in topline during the quarter.

29 Jan 2026|12:20 PM
Read More
Top Stocks for Today - 8th January 2026

Here are some of the stocks that may see significant price movement today: Infosys, Tata Steel, Cipla Limited, etc.

8 Jan 2026|07:31 AM
Read More
Top Stocks for Today - 4th November 2025

Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.

4 Nov 2025|08:01 AM
Read More
Top Stocks for Today - 14th July 2025

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

14 Jul 2025|06:30 AM
Read More
Gland Pharma Gets USFDA Clearance for Visakhapatnam Facility

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

25 Jun 2025|12:07 PM
Read More
Top Stocks for Today - 5th June 2025

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

5 Jun 2025|07:53 AM
Read More
Gland Pharma gets USFDA approval for blood pressure drug

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

4 Jun 2025|03:34 PM
Read More
Gland Pharma Q4 Net Profit Declines 3.1% to ₹186.5 Crore; Revenue Down 7.3% YoY

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

22 May 2025|08:49 AM
Read More
Gland Pharma Gets USFDA Nod for Glaucoma Drug

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

30 Apr 2025|03:40 PM
Read More
USFDA Issues Three Observations to Gland Pharma's Visakhapatnam Facility

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.

26 Feb 2025|12:22 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.